Ovarian Malignancies

Topics in Magnetic Resonance Imaging

Volumn 14, Issue 4, 2003, Pages 329-337

  Funt, Stacey A ^a,b   Hricak, Hedvig ^a,b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

MRI Cancer Genitourinary system; Neoplasm; Neoplasm Ovary; Ovary

Indexed keywords

CANCER STAGING; CLASSIFICATION; DIAGNOSTIC IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; METHODOLOGY; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARIECTOMY; OVARY CANCER; OVARY TUMOR; PATHOLOGY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REOPERATION; REVIEW; TUMOR RECURRENCE;

FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASM, RESIDUAL; OVARIAN NEOPLASMS; REOPERATION;

EID: 0242322044     PISSN: 08993459     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002142-200308000-00005     Document Type: Review

References (54)

1. Low RN. Magnetic resonance imaging of the abdomen: Applications in the oncology patients. Oncology 2000;14(suppl 3):5-14.
2. Brown DL, Doubilet PM, Miller FH, et al. Benign and malignant ovarian masses: Selection of the most discriminating gray-scale and doppler sonographic features. Radiology 1998;208:103-110.
3. Buy JN, Ghossain MA, Hassen K, et al. Characterization of adnexal masses: Combination of color Doppler and conventional sonography compared with spectral Doppler analysis alone and conventional sonography alone. AJR Am J Roentgenol 1996;166:385-393.
4. Timor-Tritsch IE, Lerner JP, Monteagudo A, et al. Transvaginal ultrasonographic characterization of ovarian masses by means of color flow-directed Doppler measurements and a morphologic scoring system. Am J Obstet Gynecol 1993;168:909-913.
5. Semelka RC, Lawrence PH, Shoenut JP, et al. Primary ovarian cancer: Prospective comparison of contrast-enhanced CT and pre- and post-contrast, fat-suppressed MRI with histologic correlation. J Magn Reson Imaging 1993;3:99-106.
6. Komatsu T, Konishi I, Madai M, et al. Adnexal masses: Transvaginal US and gadolinium-enhanced MRI assessment of intratumoral structure. Radiology 1996;198:109-115.
7. Stevens SK, Hricak H, Stern JL. Ovarian lesions: Detection and characterization with gadolinium-enhanced MRI at 1.5 T. Radiology 1991;181:481-488.
8. Kurtz AB, Tsimikas JV, Tempany CMC, et al. Diagnosis and staging of ovarian cancer: Comparative values of Doppler and conventional US, CT, and MRI correlated with surgery and histopathologic analysis report of the Radiology Diagnostic Oncology Group. Radiology 1999;212:19-27.
9. Brown DL, Zou KH, Tempany CMC, et al. Primary versus secondary ovarian malignancy: Imaging findings of adnexal masses in the radiology diagnostic oncology group study. Radiology 2001;219: 213-218.
10. Kier R, Smith RC, McCarthy SM. Value of lipid- and water-suppression MR images in distinguishing between blood and lipid within ovarian masses. AJR Am J Roentgenol 1991;158:321-325.
11. Yamashita Y, Hatanaks Y, Torashima M, et al. Characterization of sonographically indeterminate ovarian tumors with MRI: A logistic regression analysis. Acta Radiol 1997;38:572-577.
12. Ghossain MA, Buy J-N, Ligneres C, et al. Epithelial tumors of the ovary: Comparison of MRI and CT findings. Radiology 1991;181: 863-870.
13. Stevens SK, Hricak H, Campos Z. Teratomas versus cystic hemorrhagic adnexal lesions: Differentiation with proton-selective fat-saturation MRI. Radiology 1993;186:481-488.
14. Hricak H, Chen M, Coakley FV, et al. Complex adnexal masses: Detection and characterization with MRI-multivariate analysis. Radiology 2000;214:39-46.
15. Outwater EK, Huang AB, Dunton CJ, et al. Papillary projections in ovarian neoplasms: Appearances on MRI. J Magn Reson Imaging 1997;7:689-695.
16. Hussain SM, Outwater EK, Siegelman ES. MRI features of pelvic mucinous carcinomas. Eur Radiol 2000;10:885-891.
17. De Breuch Y, Ramboer K, Ghekiere J, et al. Endometrioid cystadenocarcinoma of the ovary. J Belge Radiol 1996;79:165-166.
18. Kinoshita R, Ishii K, Naganuma H, et al. MR findings of ovarian tumors with cystic components. Br J Radiol 2000;73:333-339.
19. Tanaka YO, Yoshizako T, Nishida M, et al. Ovarian carcinoma in patients with endometriosis: MR imaging findings. AJR Am J Roentgenol 2000;175:1423-1430.
20. Matsuoka Y, Ohtomo K, Araki T, et al. MR imaging of clear cell carcinoma of the ovary. Eur Radiol 2001;11:946-951.
21. Ko SF, Wan YL, Ng SH, et al. Adult ovarian granulosa cell tumors: Spectrum of sonographic and CT findings with pathologic correlation. AJR Am J Roentgenol 1999;172:1227-1233.
22. Morikawa K, Hatabu H, Togashi K, et al. Granulosa cell tumor of the ovary: MR findings. J Comput Assist Tomogr 1997;21:1001-1004.
23. Kim SH, Kang SB. Ovarian dysgerminoma: Color Doppler ultrasonographic findings comparison with CT and MRI findings. J Ultrasound Med 1995;14:843-848.
24. Outwater EK, Siegelman E, Hunt JL. Ovarian teratomas: Tumor types and imaging characteristics. Radiographics 2001;21:475-490.
25. Kim SH, Kim WH, Park KJ, et al. CT and MR findings of Krukenberg tumors: Comparison with primary ovarian tumors. J Comput Assist Tomogr 1996;20:393-398.
26. Ha HK, Baek SY, Kim SH, et al. Krukenberg's tumor of the ovary: MRI features. AJR Am J Roentgenol 1995;164:1435-1439.
27. Hann LE, Lui DM, Shi W, et al. Adnexal masses in women with breast cancer: US findings with clinical and histopathologic correlation. Radiology 2000;216:242-247.
28. Young RC, Perez CA, Hoskins WJ. Cancer of the ovary. In: De Bita VT Jr, Hellman S, Rosenberg SA, eds. Cancer: Principles and practice of Oncology, 4th ed. Philadelphia: J.B. Lippincott, 1993;1226-1261.
29. Feldman GB, Knapp RI. Lymphatic drainage of the peritoneal cavity and significance in ovarian cancer. Am J Obstet Gynecol 1974;119: 991-994.
30. Dauplat J, Hacker NF, Nieberg RK, et al. Distant metastases in epithelial ovarian carcinoma. Cancer 1987;60:1561-1566.
31. Dvoretsky PM, Richards KA, Angel C, et al. Distribution of disease at autopsy in 100 women with ovarian cancer. Hum Pathol 1988; 19:57-63.
32. International Federation of Obstetrics and Gynecology. Annual report on the results of treatment in gynecologic cancer. Int J Gynecol Obstet 1989;28:189-190.
33. Rubin SC, Markman M. Surgical staging of ovarian cancer. Bristol-Myers Oncology Division Medical Education Services. Bristol-Myers Squibb Company, Princeton, New Jersey, 1992.
34. Boente MP, Chi DS, Hoskins WJ. The role of surgery in the management of ovarian cancer: Primary and interval cytoreductive surgery. Semin Oncol 1998;25:326-334.
35. Halvorsen RA Jr, Panushka C, Oakley GJ, et al. Intraperitoneal contrast material improves the CT detection of peritoneal metastases. AJR Am J Roentgenol 1991;157:37-40.
36. Buy JN, Moss AA, Ghossian MA, et al. Peritoneal implants from ovarian tumors: CT findings. Radiology 1988;169:691-694.
37. Jacquet P, Jelinek JS, Steves MA, et al. Evaluation of computed tomography in patients with peritoneal carcinomatosis. Cancer 1993;72:1631-1636.
38. Coakley FV, Choi PH, Gougoutas CA, et al. Peritoneal metastases: Detection with spiral CT in patients with ovarian cancer. Radiology 2002;223:495-499.
39. Low RN, Semelka RC, Worawattanakul S, et al. Extrahepatic abdominal imaging in patients with malignancy: Comparison of MR imaging and helical CT with subsequent surgical correlation. Radiology 1999;210:625-632.
40. Low RN, Carter WD, Saleh F, et al. Ovarian cancer: Comparison of findings with perfluorocarbon-enhanced MR imaging: In-111-CYT-103 immunoscintigraphy and CT. Radiology 1995;195:391-400.
41. Sabbatini P, Spriggs D. Salvage therapy for ovarian cancer. Oncology 1998;12:833-843.
42. Bristow RE, Lagasse LD, Karlan BY. Secondary surgical cytoreduction for advanced epithelial ovarian cancer: Patient selection and review of the literature. Cancer 1996;78:2049-2062.
43. Griffiths GT. Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma. Natl Cancer Inst Monogr 1975;42:101-104.
44. Curtin JP, Malik R, Venkatraman ES, et al. Stage IV ovarian cancer: Impact of surgical debulking. Gynecol Oncol 1997;64:9-12.
45. Eisenkop SM, Friedman RL, Wang HJ. Complete cytoreductive surgery is feasible and maximizes survival in patients with advanced epithelial ovarian cancer: A prospective study. Gynecol Oncol 1998; 69:103-108.
46. Meyer JI, Kennedy AW, Friedman R, et al. Ovarian carcinoma: Value of CT in predicting success of debulking surgery. AJR Am J Roentgenol 1995;165:875-878.
47. Bristow RE, Duska LR, Lambrou NC, et al. A model for predicting surgical outcome in patients with advanced ovarian carcinoma using computed tomography. Cancer 2000;89:1532-1540.
48. Nelson BE, Rosenfield AT, Schwartz PE. Preoperative abdomino-pelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 1993;11:166-172.
49. Williams L. The role of secondary cytoreductive surgery in epithelial ovarian malignancies. Oncology 1992;6:25-32.
50. Segna RA, Dottino PR, Mandeli JP, et al. Secondary cytoreduction for ovarian cancer following cisplatin therapy. J Clin Oncol 1993; 11:434-439.
51. Gadducci A, Iacconi P, Cosio S, et al. Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer. Gynecol Oncol 2000;79:344-49.
52. Zang RY, Zhang ZY, Li ZT, et al. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer. Eur J Surg Oncol 2000;26:798-804.
53. Janicke F, Holscher M, Kuhn W, et al. Radical surgical procedure improves survival time in patients with recurrent ovarian cancer. Cancer 1992;70:2129-2136.
54. Ozols RF, Rubin SC, Thomas GM, et al. Epithelial ovarian cancer. In: Hoskins WJ, Perez CA, Young RC, eds. Principles and Practice of Gynecologic Oncology. Philadelphia: Lippincott Williams & Wilkins, 2000;981-1059.